Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$12.80 -0.32 (-2.44%)
At close: Oct 23, 2026 · 4:00 PM EDT

Eloxx Pharmaceuticals (ELOX) Gains from Investment Securities (2010 - 2013)

Updated

Analysis

Eloxx Pharmaceuticals (ELOX) Gains from Investment Securities (2010 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Eloxx Pharmaceuticals 87.44 Mn 13.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 99,760.00
Mar 31, 2013 227,539.00
Dec 31, 2012 64,440.00
Sep 30, 2012 -20,148.00
Jun 30, 2012 164,104.00
Mar 31, 2012 76,048.00
Dec 31, 2011 -39,392.00
Sep 30, 2011 271,703.00
Jun 30, 2011 156,030.00
Mar 31, 2011 -16,177.00
Dec 31, 2010 149,910.00
Sep 30, 2010 319,476.00
API Access

Eloxx Pharmaceuticals Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=ELOX&period=max&api_key=YOUR_API_KEY